Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
TPCE Banner

Live (Knoxville) - Assimilation of Biosimilars Into Clinical Use: Challenges Facing the Pharmacist


This website is for processing credits after the program only. In order to register for the meeting, and recieve more information, please contact Dr. Richard Breeden at rbreeden@southcollegetn.edu. 

Date: Oct 25, 2018 06:00 PM - 07:00 PM

Fee

$0.00

CE Hours

1.00

Activity Type

  • Knowledge

Accreditation(s)

Accreditation Council for Pharmacy Education
The Tennessee Pharmacists Consortium for Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

 

Objectives

  • Review the physicochemical properties of biologics
  • Describe and differentiate among biologics and biosimilars
  • Review the processes used to manufacture biologics
  • Identify and apply product criteria to evaluate the reliability and clinical utility of biosimilars
  • Discuss the needed knowledge to educate colleagues regarding the proper assimilation of biosimilars into clinical practice

Speaker(s)/Author(s)

Eric Dadey, B.S., M.S., M.S., Ph.D.
Associate Professor of Pharmaceutical Sciences, South College School of Pharmacy


Brief Bio : Dr. Dadey’s research interests focus on the use of dynamic and static light scattering techniques to characterize physical interactions between biologics and endogenous biomolecules and their application in the design of smart drug delivery systems. Dr. Dadey has more than 20 years pharmaceutical industry experience in development of oral and parenteral drug products utilizing novel drug delivery systems. His expertise spans the entire product development process, from API characterization, formulation, analytical method development, preclinical and GLP safety assessment studies, through clinical study design and conduct, pharmacokinetic assessment, technology transfer, scale-up and cGMP manufacture, management of US and international regulatory submissions and correspondence, and generation of new intellectual property.

Activity Number

0575-0000-18-093-L01-P
Date: 10/25/18
Time: 06:00 PM - 07:00 PM

CE Hours

1.00